Arteris is trading 5.4% lower at $19.80 in pre-market amid semiconductor-sector weakness; no company-specific catalyst for the decline was identified. - Semiconductor shares are under pressure after Lam Research reported supply constraints delaying shipments and warned of a lower China revenue contribution. - Broader markets are also lower, reinforcing a cautious backdrop; Arteris’s latest announcement said third-quarter results will be released November 5.